Physician profile
Jon Mcgregor
NPI 1619925575
$1,133.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $301 · 2021: $17.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $176.82 | 2019-2020 | |
| Amarin Pharma, INC. | $172.75 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $169.89 | 2019-2020 | |
| Amgen INC. | $125.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.86 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $106.32 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.82 | 2019-2021 | |
| Boston Scientific Corporation | $41.77 | 2019-2020 | |
| Pfizer INC. | $35.87 | 2019-2020 | |
| Astellas Pharma US INC | $23.27 | 2020 | |
| Vifor Pharma, INC. | $22.98 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.61 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.52 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.21 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Mcgregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.